Antioxidant and antimicrobial activity of 5-methyl-2-(5-methyl-1,3- diphenyl-1H-pyrazole-4-carbonyl)-2,4-dihydro-pyrazol-3-one

International Journal of Biomedical Science

Volumn 5, Issue 4, 2009, Pages 359-368

  Umesha, K B ^a   Rai, K M Lokanatha ^b   Harish Nayaka, M A ^b  

^a UNIVERSITY OF MYSORE   (India)

^b UNIVERSITY OF MYSORE   (India)

Author keywords

Antimicrobial; Antioxidant; Pyrazoles

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2 [3 (3,4 DIMETHOXY PHENYL) 5 METHYL 1 PHENYL 1H PYRAZOLE 4 CARBONYL] 5 METHYL 2,4 DIHYDRO PYRAZOL 3 ONE; 2 [3 (4 CHLORO PHENYL) 5 METHYL 1 PHENYL 1H PYRAZOLE 4 CARBONYL] 5 METHYL 2,4 DIHYDRO PYRAZOLE 3 ONE; 2 [3 (4 DIMETHYLAMINO PHENYL) 5 METHYL 1 PHENYL 1H PYRAZOLE 4 CARBONYL] 5 METHYL 2,4 DIHYDRO PYRAZOL 3 ONE; 2 [3 (4 METHOXY PHENYL) 5 METHYL 1 PHENYL 1H PYRAZOLE 4 CARBONYL ] 5 METHYL 2,4 DIHYDRO PYRAZOL 3 ONE; 5 METHYL 2 (5 METHYL 1 PHENYL 3 PENTO TOLYL 1 PHENYL 1H PYRAZOLE 4 CARBONYL) 2,4 DIHYDRO PYRAZOL 3 ONE; 5 METHYL 2 (5 METHYL 1,3 DIPHENYL 1H PYRAZOLE 4 CARBONYL) 2,4 DIHYDRO PYRAZOL 3 ONE; 5 METHYL 2 [5 METHYL 1 PHENYL 3 (3,4,5 TRIMETHOXYPHENYL) 1H PYRAZOLE 4 CARBONYL] 2,4 DIHYDRO PYRAZOL 3 ONE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIOXIDANT; GRISEOFULVIN; PYRAZOLE DERIVATIVE; STREPTOMYCIN SULFATE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC BIOSYNTHESIS; ANTIFUNGAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CHEMICAL INTERACTION; CONTROLLED STUDY; CYCLOADDITION; DEHYDROGENATION; DNA DETERMINATION; DRUG DETERMINATION; DRUG SYNTHESIS; ERYTHROCYTE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; OXIDATIVE STRESS; STAPHYLOCOCCUS AUREUS;

EID: 77953368197     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Huisgen R. "1,3-dipolar cycloaddition chemistry" edited by A Padwa, (Wiley Interscience, New York). 1984.
2. Caramella P, Grunanger P. "1,3-dipolar cycloaddition chemistry", edited by A. Padwa, (Wiley Interscience, New York). 1984; 1:337.
3. a) Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics, (Macmillan, New York). 1980;
4. b) Wachter M, Ferro M. US patent. 1989; 4826868. Chem Abstr. 1988; 108:186735;
5. c) Argentieri D, Ritchie D, Tolman E, Ferro M, et al. The FASEB J Antiinlammatory Agents, 1988; 4(2): A369.
6. a) Sector HV, De Bardelaben JF. J Med Chem. 1971; 14:997.
7. b) Bauer VJ, Fanshawe WJ, Dalalian HP, Safir SR, et al. J Med Chem. 1968; 11:981.
8. c) Corsi G, Germani C, Palazzo G, Rani Silvest B, Barcellone PS. J Med Chem. 1976; 19:778.
9. d) Dueham NN, Chesnut RW, Hashen MM, Berlin KD. J Med Chem. 1976; 19:229.
10. Takaishi H, Hamaguchi H, Yanaka KNA. Jpn Kokai Tokkyo, Koho Jp. 1987; 6253: 969-970. Chem Abstr, 1987; 107: 115585 and 96174.
11. Bochis RJ, Dybas RA, Rogers EF. US pat, 4, 622, 330 (1986); Chem Abstr, 1987; 106: 102279.
12. a) Urmila Gupta, Vineeta Sareen, Sanjana Chugh. Indian J. Heterocyclic Chem., 2004; 13: 351.
13. b) Jayachandran E, Srinivasa GM. Indian J. Heterocyclic Chem., 2006; 15: 413.
14. Dhol PN, Achary TE, Nayak A. J Indian Chem Soc. 1975; 52:1196.
15. Huisgen R, Seidel M, Sauer J, McFarland JM, Wallibillich G. J org Chem. 1959; 24:892.
16. Huisgen R, Seidel M, Wallibillich G, Knupfer HH. Tetrahedron. 1962; 17:3.
17. Gladstone WA, Aylward JB, Norman ROC. J. Chem. Soc ©. 1969; 2587.
18. Rai KML, Hassner A. Synth. Commun. 1989; 19:2799.
19. Rai KML, Ninganna L. Synthe. Commun. 1997; 27:3737.
20. Marky M, Meier H, Wunderli A, Hemigartner H, et al. Helv Chem Acta. 1978; 61:1477.
21. a) Shawali AS, Hassaneen HM. Tetrahedron. 1973; 29:121-124.
22. b) Shawali AS, Hassaneen HM, Sami M, Fahham HM. J. Heterocyclic Chem. 1976; 13:1137-1140.
23. c) Shawali AS, Cyril Parkanyi. J. Heterocyclic Chem. 1980; 17: 833-854.
24. a) Baruah AK, Prajapati D, Sandhu JS. J. Chem. Soc. Perkin Trans. 1987; 1: 1995.
25. b) Baruah AK, Prajapati D, Sandhu JS. Tetrahedron. 1988; 44:6137.
26. Prajapati D, Sandhu JS, Kametani T, Nagase H, et al. Heterocycles. 1985; 23: 1123.
27. Mogilaiah K, Reddy CS. Indian J. Chem. Sec.B, 2002; 41B:1450.
28. Aly EA, El-Borai MA, Barren MA. Indian J. Chem. Sec.B, 2004; 43B:1355.
29. Desai NC, Nayan Bhatt, Mukesh Kumar. Indian J. Heterocyclic Chem. 2008; 17: 277-278.
30. a) Padmavathi V, Reddy KV, Balaiah A, Padmaja A, Reddy DB. Synth Commun. 2002; 32:1227.
31. b) Padmavathi V, Reddy KV, Balaiah A, Reddy TVR, et al. Heteroatom Chem. 2002; 13:677.
32. c) Padmavathi V, Reddy KV, Padmaja A, Reddy DB. Phosphorus Sulfur and Silicon. 2003; 178:171.
33. Bacchetti T. Gazz. Chem. Ital. 1961; 91:866.
34. Umesha KB, Rai KML, Ajaykumar K. Indian J. Chem. Sec.B, 2002; 41B:1450.
35. Suwalsky M, Orellana P, Avello M, Villena F. Protective effect of Ugni molinae Turcz against oxidative damage of human erythrocytes. Food and Chemical Toxicology. 2007; 45:130-135.
36. Manna C, Galletti P, Cucciolla V, Montedoro G, Zappia V. Olive oil hydroxytyrosol protects human erythrocytes against oxidative damages. Journal of Nutritional Biochemistry. 1999; 10:159-165.
37. Lai LS, Chou ST, Chao WW. Studies on the antioxidant activities of Hsian-tsao (Mesona procumbens Hemsl) leaf gum. Journal of Agricultural Food chemistry. 2001; 49:963-968.
38. Yen GC, Chen HY. Antioxidant activity of various tea extracts in relation to their Antimutagenicity. Journal of Agricultural Food Chemistry. 1995; 43:27-32.
39. Kumar GS, Harish Nayaka, Shylaja MD, Salimath PV. Free and bound phenolic antioxidants in amla (Emblica officinalis) and turmeric (Curcuma longa). Journal of Food Composition and Analysis. 2006; 19:446-452.
40. Anon, Pharmacopoeia of India (The Indian Pharmacopoeia) 3rd edition. Government of India, New Delhi: Ministry of Health and Family Welfare. 1996.